These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7518217)

  • 1. Effect of oxetanocin G, a novel nucleoside analog, on DNA synthesis by hepatitis B virus virions.
    Nagahata T; Kitagawa M; Matsubara K
    Antimicrob Agents Chemother; 1994 Apr; 38(4):707-12. PubMed ID: 7518217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of triphosphate derivatives of oxetanocin G and related compounds on eukaryotic and viral DNA polymerases and human immunodeficiency virus reverse transcriptase.
    Izuta S; Shimada N; Kitagawa M; Suzuki M; Kojima K; Yoshida S
    J Biochem; 1992 Jul; 112(1):81-7. PubMed ID: 1385392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of inhibition of human cytomegalovirus replication by oxetanocin G.
    Daikoku T; Yamamoto N; Saito S; Kitagawa M; Shimada N; Nishiyama Y
    Biochem Biophys Res Commun; 1991 Apr; 176(2):805-12. PubMed ID: 1851005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of human cytomegalovirus replication by a novel nucleoside, oxetanocin G.
    Nishiyama Y; Yamamoto N; Takahash K; Shimada N
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1053-6. PubMed ID: 2847638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents.
    Iyer RP; Jin Y; Roland A; Morrey JD; Mounir S; Korba B
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2199-205. PubMed ID: 15155222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncompetitive inhibition of hepatitis B virus reverse transcriptase protein priming and DNA synthesis by the nucleoside analog clevudine.
    Jones SA; Murakami E; Delaney W; Furman P; Hu J
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4181-9. PubMed ID: 23774432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2'-deoxyguanosine.
    Price PM; Banerjee R; Jeffrey AM; Acs G
    Hepatology; 1992 Jul; 16(1):8-12. PubMed ID: 1319957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
    Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
    Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
    Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priming of duck hepatitis B virus reverse transcription in vitro: premature termination of primer DNA induced by the 5'-triphosphate of fialuridine.
    Staschke KA; Colacino JM
    J Virol; 1994 Dec; 68(12):8265-9. PubMed ID: 7525986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of resistance to carbocyclic oxetanocin G in herpes simplex virus type 1 and genetic analysis of resistant mutants.
    Hu N; Shiota H
    Acta Pharmacol Sin; 2004 Jul; 25(7):921-6. PubMed ID: 15210066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model.
    Nagahata T; Araki K; Yamamura K; Matsubara K
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2042-5. PubMed ID: 1416898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
    Delaney WE; Miller TG; Isom HC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil.
    Balakrishna Pai S; Liu SH; Zhu YL; Chu CK; Cheng YC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):380-6. PubMed ID: 8834884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New targets and inhibitors of HBV replication to combat drug resistance.
    Cheng YC; Ying CX; Leung CH; Li Y
    J Clin Virol; 2005 Dec; 34 Suppl 1():S147-50. PubMed ID: 16461217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of oxetanocin-G, a novel nucleoside against the woodchuck hepatitis virus.
    Ikeda N; Kaneko S; Shimoda A; Inagaki Y; Unoura M; Okada M; Yonekawa Y; Takahashi K; Kobayashi K
    J Antimicrob Chemother; 1994 Jan; 33(1):83-9. PubMed ID: 8157578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine.
    King RW; Ladner SK; Miller TJ; Zaifert K; Perni RB; Conway SC; Otto MJ
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3179-86. PubMed ID: 9835512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.
    Clark DN; Hu J
    Antiviral Res; 2015 Nov; 123():132-7. PubMed ID: 26408354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.